CIK 0001111485 · Accelerated filer
RxSight, Inc.
Sign in to watch- Ticker
- RXST
- Exchange
- Nasdaq
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943268801
- Phone
- 949-521-7822
- Business address
- 100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA, 92656
- Former names
- CALHOUN VISION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,951
- in 4 filings
Net −$117,951. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 86 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-26 | Goldshleger Ilya See remarks | Option exercise · Stock Option (right to buy) 10b5-1 | −3,105 | 102,802 | ||
| 2024-09-23 | Goldshleger Ilya See remarks | Option exercise 10b5-1 | +3,100 | $15.08 | $47K | 45,346 |
| 2024-09-23 | Goldshleger Ilya See remarks | Sale 10b5-1 | −2,950 | $52.62 | $155K | 42,396 |
| 2024-09-23 | Goldshleger Ilya See remarks | Sale 10b5-1 | −150 | $53.53 | $8K | 42,246 |
| 2024-09-23 | Goldshleger Ilya See remarks | Option exercise · Stock Option (right to buy) 10b5-1 | −3,100 | 105,907 | ||
| 2024-09-20 | Goldshleger Ilya See remarks | Option exercise 10b5-1 | +3,100 | $15.08 | $47K | 45,346 |
| 2024-09-20 | Goldshleger Ilya See remarks | Sale 10b5-1 | −3,100 | $53.19 | $165K | 42,246 |
| 2024-09-20 | Goldshleger Ilya See remarks | Option exercise · Stock Option (right to buy) 10b5-1 | −3,100 | 109,007 | ||
| 2024-09-17 | Goldshleger Ilya See remarks | Option exercise 10b5-1 | +3,100 | $15.08 | $47K | 45,346 |
| 2024-09-17 | Goldshleger Ilya See remarks | Sale 10b5-1 | −3,100 | $56.11 | $174K | 42,246 |
| 2024-09-17 | Goldshleger Ilya See remarks | Option exercise · Stock Option (right to buy) 10b5-1 | −3,100 | 112,107 | ||
| 2024-08-09 | Kurtz Ronald M MD President & CEO | Option exercise | +7,650 | $15.08 | $115K | 61,150 |
| 2024-08-09 | Kurtz Ronald M MD President & CEO | Option exercise | +2,300 | $4.34 | $10K | 63,450 |
| 2024-08-09 | Kurtz Ronald M MD President & CEO | Option exercise · Stock Option (right to buy) | −7,650 | 19,186 | ||
| 2024-08-09 | Kurtz Ronald M MD President & CEO | Option exercise · Stock Option (right to buy) | −2,300 | 0 | ||
| 2024-08-07 | Weinberg Eric See remarks | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-08-07 | Goldshleger Ilya See remarks | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-08-07 | Thunen Shelley B See remarks | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-08-05 | Goldshleger Ilya See remarks | Sale 10b5-1 | −1,145 | $38.80 | $44K | 50,101 |
| 2024-08-05 | Goldshleger Ilya See remarks | Sale 10b5-1 | −1,855 | $39.43 | $73K | 48,246 |
Page 10 of 15 · 300 trades